This $663,662 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to adapt and evaluate an evidence-based substance use prevention intervention for youth in foster care. The primary objectives are to: Adapt core components of existing evidence-based interventions to be tailored for the needs of youth in foster care and suitable for delivery by Court Appointed Special Advocates (CASAs). Conduct a large-scale hybrid...
The National Institute on Drug Abuse (NIDA) awarded a $264,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Innovation Research And Training, Inc. (IRT), a woman-owned small business research organization based in Durham, North Carolina. The purpose of this 3-year project, beginning September 2024, is to evaluate the "Substance of Change: Building Assets in Mentees Affected by Substance Misuse" (SOC), an interactive, multimedia, web-based,...
This federal Project Grant award, with ID K12DA061526, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,472,891 award will support the Vanderbilt Oregon Collaborative Scholar Training in Addiction Research (COSTAR) program, which aims to train and mentor the next generation of substance use researchers. The COSTAR program will provide 5 years of support for a minimum of three faculty scholars at Vanderbilt...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $388,857 to The Ohio State University to conduct research examining the direct and indirect effects of disasters on drug-related outcomes. The study will use quasi-experimental methods and a robust federal disaster database to analyze the impact of disasters on aggregate-level mortality and individual-level substance use over an extended...
This $1,338,750 federal Project Grant was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports the development and piloting of a brief, digitally-enhanced intervention called IMPROVE to reduce alcohol use among individuals receiving medication for opioid use disorder (MOUD). The project has two main objectives: To adapt the IMPROVE intervention's content, delivery, and digital tools through expert and...
This federal Project Grant award of $3,503,736 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and test a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in county legal systems. The key products and services to be delivered under this 2-year R61 phase and 3-year R33 phase award include: 1) co-designing a multilevel SUD/overdose prevention strategy with...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to optimize an online behavioral intervention to prevent and reduce substance use among high school seniors, a critical transition period. The $1,702,558 award will fund the development and evaluation of an innovative, technology-driven intervention targeting social influences linked to substance use. The project will employ human-centered...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a study to refine and pilot the R3 Supervision Strategy in substance use disorder (SUD) treatment programs. The $1,126,100 award, effective July 15, 2024, will allow the University of Arkansas for Medical Sciences (UAMS) to partner with SUD providers to modify the evidence-based R3 supervision strategy for SUD settings and conduct two pilot...
The Ohio Department of Health was awarded a $6 million project grant from the Department of Justice's Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and other Substances Use Program to implement evidence-based substance use disorder treatment and harm reduction services in six counties. The three-year award will support expanding harm reduction activities and education targeting Black and Hispanic populations in high-risk areas; improving access to medication-assisted...
This $1,607,146 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop community-based technology interventions to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The award supports a participatory approach to create English and Spanish-language multimedia materials, including short videos and graphic novels, to address...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $953,802 to The Ohio State University from September 30, 2024 to August 31, 2025. The project aims to test the effectiveness of a supervision coaching strategy called COSTARS to promote workforce stability and implementation of the Sobriety Treatment and Recovery Teams (START) program in Ohio's child welfare system. COSTARS focuses on improving supportive supervision practices, destigmatizing substance use disorder, and enhancing collaboration between child welfare and substance use disorder treatment systems. The project involves developing and refining the COSTARS model, training peer and expert supervision coaches, and conducting an implementation trial to examine the effects on staff retention, service timeliness, and parental outcomes. Relevant sub-awards include support from the Public Children Services Association of Ohio to manage COSTARS operations, and from the University of California, Berkeley and Chestnut Health Systems to provide implementation science expertise and technical assistance coaching.